265 related articles for article (PubMed ID: 26250408)
1. Palmoplantar pustular psoriasis induced by adalimumab: a case report and literature review.
Ibis N; Hocaoglu S; Cebicci MA; Sutbeyaz ST; Calis HT
Immunotherapy; 2015; 7(7):717-20. PubMed ID: 26250408
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?
Joyau C; Veyrac G; Dixneuf V; Jolliet P
Clin Exp Rheumatol; 2012; 30(5):700-6. PubMed ID: 22935567
[TBL] [Abstract][Full Text] [Related]
4. Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases.
Famenini S; Wu JJ
J Drugs Dermatol; 2013 Aug; 12(8):939-43. PubMed ID: 23986169
[TBL] [Abstract][Full Text] [Related]
5. Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases.
Ko JM; Gottlieb AB; Kerbleski JF
J Dermatolog Treat; 2009; 20(2):100-8. PubMed ID: 18923992
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction.
Sfikakis PP; Iliopoulos A; Elezoglou A; Kittas C; Stratigos A
Arthritis Rheum; 2005 Aug; 52(8):2513-8. PubMed ID: 16052599
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical psoriasis following anti-TNF therapy in ankylosing spondylitis: A population-based cohort study.
Bae JM; Kwon HS; Kim GM; Park KS; Kim KJ
J Allergy Clin Immunol; 2018 Sep; 142(3):1001-1003.e2. PubMed ID: 29859201
[No Abstract] [Full Text] [Related]
9. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-α inhibitors: the Mayo Clinic experience, 1998 to 2010.
Shmidt E; Wetter DA; Ferguson SB; Pittelkow MR
J Am Acad Dermatol; 2012 Nov; 67(5):e179-85. PubMed ID: 21752492
[TBL] [Abstract][Full Text] [Related]
10. New-onset psoriasis associated with adalimumab: a report of two cases.
Glenn CJ; Kobraei KB; Russo JJ
Dermatol Online J; 2011 Sep; 17(9):15. PubMed ID: 21971280
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis.
Lee JW; Kang JH; Yim YR; Kim JE; Wen L; Lee KE; Park DJ; Kim TJ; Park YW; Lee SS
PLoS One; 2015; 10(7):e0131864. PubMed ID: 26176701
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
[TBL] [Abstract][Full Text] [Related]
13. Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children.
Perman MJ; Lovell DJ; Denson LA; Farrell MK; Lucky AW
Pediatr Dermatol; 2012; 29(4):454-9. PubMed ID: 21995665
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action.
Collamer AN; Guerrero KT; Henning JS; Battafarano DF
Arthritis Rheum; 2008 Jul; 59(7):996-1001. PubMed ID: 18576309
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions.
de Gannes GC; Ghoreishi M; Pope J; Russell A; Bell D; Adams S; Shojania K; Martinka M; Dutz JP
Arch Dermatol; 2007 Feb; 143(2):223-31. PubMed ID: 17310002
[TBL] [Abstract][Full Text] [Related]
16. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
Capkin E; Karkucak M; Yayli S; Aydin Çapkin A; Tosun M
J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
[No Abstract] [Full Text] [Related]
17. Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis.
Sauder MB; Glassman SJ
Int J Dermatol; 2013 May; 52(5):624-8. PubMed ID: 23489057
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF-associated palmoplantar pustulosis.
Pyrpasopoulou A; Chatzimichailidou S; Simoulidou E; Aslanidis S
J Clin Rheumatol; 2010 Apr; 16(3):138-9. PubMed ID: 20216329
[No Abstract] [Full Text] [Related]
19. Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: a 'class effect' of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?
Rallis E; Korfitis C; Stavropoulou E; Papaconstantis M
J Dermatolog Treat; 2010 Jan; 21(1):3-5. PubMed ID: 19701844
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab.
Gomes KW; Benevides AN; Vieira FJ; Burlamaqui MP; Vieira Mde A; Fontenelle LM
Rev Bras Reumatol; 2012; 52(3):447-52. PubMed ID: 22641598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
